JENNIFER VAZQUEZ: Open Payments
NPI 1598302341 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,558 in 54 payments from 14 companies in 2025. Trend: 2023 $821 · 2024 $1,547 · 2025 $1,558
Food & beverage: $1,558
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $355 |
| AstraZeneca Pharmaceuticals LP | 12 | $269 |
| Boston Scientific Corporation | 3 | $183 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $164 |
| Novo Nordisk Inc | 5 | $129 |
| Lilly USA, LLC | 4 | $84 |
| PFIZER INC. | 3 | $68 |
| GlaxoSmithKline, LLC. | 2 | $59 |
| Abbott Laboratories | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
Products named: REZDIFFRA, Kerendia, SpyGlass Discover, AIRSUPRA, FARXIGA, Ozempic, TRELEGY ELLIPTA, FREESTYLE LIBRE 3.
Industry payments across IL — which companies pay providers there.
